A Food and Drug Administration advisory panel recommended on Friday that compounding pharmacies be allowed to manufacture the ...

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes ...

A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Mirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the state of men’s ...

Timothy Westlake, an emergency doctor nominated to head SAMHSA, has been active in addiction policy in Wisconsin.

The White House and the Department of Health and Human Services will convene experts to discuss the benchmarking and ...

New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could ...

A study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and support.

The FDA said Monday it is still focused on lettuce from Taylor Farms as the source of a multistate outbreak of ...